DexCom, Inc. Common Stock (NASDAQ: DXCM) last traded at $84.11, down 0.36% on the session. The quote above updates while this page is open; the figures below are drawn from DexCom, Inc. Common Stock’s own filings and are restated only when a new one is published.
DexCom, Inc. Common Stock trades on NASDAQ under the ticker DXCM. Its market capitalisation is $31.74 billion.
Valuation measures for DexCom, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $31.74B |
|---|---|
| Enterprise value | $34.47B |
| P/E ratio | 33.38 |
| Price / sales | 6.39 |
| Price / book | 12.11 |
| Beta | 0.58 |
Trailing-twelve-month figures tagged in DexCom, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $4.97B |
|---|---|
| Net income (TTM) | $999.70M |
| EPS (TTM) | $2.52 |
| Gross margin | 62.47% |
| Operating margin | 22.92% |
| Return on equity | 38.14% |
| Cash | $1.10B |
Range and volume for DXCM over the past 52 weeks.
| 52-week high | $92.59 |
|---|---|
| 52-week low | $54.11 |
| Volume | 3.15M |
| Average volume | 4.41M |
| Previous close | $84.41 |
Invest a chosen dollar amount in DexCom, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell DXCM.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.